Trials / Conditions / HER2 + Gastric Cancer
HER2 + Gastric Cancer
4 registered clinical trials studyying HER2 + Gastric Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroeso NCT07176312 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Phase 2 |
| Not Yet Recruiting | Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Su NCT06881017 | China Medical University, China | Phase 2 |
| Recruiting | A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871 | Iambic Therapeutics, Inc | Phase 1 |
| Completed | A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cance NCT01598077 | Novartis Pharmaceuticals | Phase 1 |